Subscribe to RSS
DOI: 10.1055/s-2008-1079197
Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases
Introduction: Inhibins are dimeric glycoproteins, composed of an alpha-subunit (inhibin-α) and one of two possible beta-subunits (βA or βB), with substantial roles in human reproduction and in endocrine-responsive tumours. Aims of this study were to determine the distribution of inhibin-α, -βA and -βB in malignant human endometrial tissue and the assessment of an association with specific clinicopathologic tumour features and clinical outcome.
Materials and Methods: A series of 302 endometrial cancer tissue samples were immunohistochemically analysed with monoclonal antibodies against inhibin-subunits. The inhibin-α subunit showed a significant association with histological grading, surgical staging, lymph node status and diabetes in patients with endometrial cancer.
Results: Interestingly, loss of inhibin-α expression resulted in a poorer survival of endometrial cancer patients. Additionally, survival analysis demonstrated that inhibin-α immunoreactivity was an independent prognostic factor for progression-free survival, cause-specific survival as well as overall survival. In contrast, although inhibin-βA- and -βB subunits showed a significant association between endometrial histological subtypes and histological grading, both subunits were not found to be associated with survival in endometrial cancer patients.
Discussion: Therefore, inhibin-α immunostaining might be used as a simple and efficient marker to identify high-risk patients leading in the selection of patients for an aggressive adjuvant therapy.